SASP can enhance anti‐tumour immune responses via activating IFN signal transduction, augmenting MHC class I molecules and stimulating senescence‐specific auto‐peptides of CD8+ T cells, which efficiently activate dendritic cells and antigen‐specific CD8+ T cells [41]. This evidence concerns the gene CD8A and neoplasm.